BioLargo, Inc. BLGO
$0.09
$0.00-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.25M | 1.12M | 617.00K | 1.10M | 2.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.25M | 1.12M | 617.00K | 1.10M | 2.78M |
| Cost of Revenue | 573.00K | 657.00K | 489.00K | 731.00K | 1.36M |
| Gross Profit | 675.00K | 458.00K | 128.00K | 372.00K | 1.42M |
| SG&A Expenses | 3.32M | 2.76M | 3.47M | 6.94M | 2.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.98M | 4.32M | 4.61M | 8.28M | 4.58M |
| Operating Income | -3.73M | -3.20M | -4.00M | -7.18M | -1.80M |
| Income Before Tax | -4.00M | -3.41M | -4.14M | -7.24M | -1.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.00M | -3.41M | -4.14M | -7.24M | -1.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.23M | 1.12M | 1.19M | 765.00K | 690.00K |
| Net Income | -2.77M | -2.29M | -2.95M | -6.48M | -1.19M |
| EBIT | -3.73M | -3.20M | -4.00M | -7.18M | -1.80M |
| EBITDA | -3.67M | -3.14M | -3.96M | -7.13M | -1.75M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 320.98M | 318.70M | 314.29M | 308.97M | 303.20M |
| Average Diluted Shares Outstanding | 320.98M | 318.70M | 314.29M | 308.97M | 303.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |